| |
|
|
|
CASI Pharmaceuticals Inc.  
|
|
0 (0%) |
|
|
Open: |
|
Pre close: |
|
Target:
|
4.10
|
|
High: |
|
Low: |
|
Resistance:
|
3.51
3.82
|
|
Volume: |
|
Market Cap: |
0M |
Support:
|
3.00
2.50
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.36
 |
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
3.34  |
Signal(12,26,9): |
0.08 |
|
MA(100): |
3.19 |
Stochastic Oscillator |
%K(14,3):
|
32.42 |
|
MA(250): |
3.46 |
%D(3): |
39.12 |
|
Average Volume(K) |
3-Month: |
20150
|
52-Week |
High:
|
5.92 |
|
10-Days: |
31693 |
Low: |
2.73 |
|
RSI |
RSI(14):
|
51.34 |
Change(%): |
-41.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.444 |
Return on Equity (ttm) |
-43.0 |
Shares Out. (M) |
95.72 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-22.0 |
Shares Float (M) |
35.10 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
41.36 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
21.00 |
|
Forward EPS |
-0.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
4590 |
|
Book Value (p.s.) |
0.930 |
EBITDA (p.s.) |
-0.352 |
P/E |
-7.55 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.60 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-32.92 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-28.95 |
P/CF |
-9.74 |
|
|
|
|
|
|
